Please provide your email address to receive an email when new articles are posted on . Accurately diagnosing ankylosing spondylitis is a challenge for physicians, who must rely on a combination of ...

Please provide your email address to receive an email when new articles are posted on . While rheumatic diseases like ankylosing spondylitis confound clinicians, tumor necrosis factor inhibitors have ...

Ankylosing spondylitis (AS) is a chronic inflammatory condition that mainly affects the spine. The condition usually requires medical treatments, but some home remedies can also reduce symptoms. AS is ...

Ankylosing spondylitis (AS) is a type of arthritis that causes joint inflammation and back pain and stiffness. Though it’s thought to be most common in white men, the disease also affects women and ...

Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints (those between the spine and hipbone). Less commonly, AS can affect other joints such ...

Pfizer Inc. announced positive results from a phase 3 investigational study evaluating the safety and efficacy of tofacitinib in adults with active ankylosing spondylitis (AS). Tofacitinib is not ...

It can be tough to live with a painful, lifelong condition like ankylosing spondylitis. You may have trouble working, or doing activities you’ve always enjoyed. You may feel like friends, family, and ...

The US Food and Drug Administration has approved upadacitinib (Rinvoq) as an oral treatment for active ankylosing spondylitis in adults, its manufacturer AbbVie announced April 29. Upadacitinib, a ...

A change in medication may cause new or worsening symptoms of ankylosing spondylitis, even if other symptoms improve. A doctor may need to prescribe a combination of medications to relieve a person’s ...